'Risk ratio' presentation slideshows

Statistical inference: CLT, confidence intervals, p-values

1.52k views • 82 slides

Market Risk

Market Risk FIN 653 From Saunders and Cornett Ch. 10 Market Risk I. Market Risk Management Market risk is defined as the uncertainty of an FI's earnings resulting from changes in market conditions such as the price of an asset, interest rates, market volatility, and market liquidity.

2.04k views • 68 slides

Clostridium difficile

Clostridium difficile. David B. Blossom, MD MS Division of Healthcare Quality Promotion Coordinating Center for Infectious Diseases Centers for Disease Control and Prevention. Objectives. Review of Clostridium difficile Discuss the transmission and virulence of C. difficile

1.38k views • 60 slides

Cryptorchidism

Cryptorchidism. One of the most common male developmental abnormalities 27,000 orchidopexies annually in USA 89% of untreated males with bilateral cryptorchidism develop azospermia Lifetime risk of neoplasia 2-3% 4 fold higher than average risk. Issues. Definitions & epidemiology

2.09k views • 58 slides

Bootstrap and Cross-Validation

1.58k views • 52 slides

RISK PYRAMID

RISK PYRAMID. Risks, Trends, Prevalence, & FUTURE of Asthma locally & globally. Dr. Yoga Nathan Senior Lecturer in Public Health GEMS UL. Talk Outline. Risks & Trends Asthma trends in Ireland & Globally Prevalence Risk Pyramid. Learning Outcomes.

991 views • 49 slides

For more information, visit: conference.apbs

D6- Beginning to Embed Culturally Responsive Practices in the Universal System Jennifer Rose, Ph. D., Milaney Leverson, Kent Smith Key Words: Equity, PBIS Foundations, Tier 1, Assessment. Miami, FL Hyatt Regency Miami. March 11-14, 2020. For more information, visit: conference.apbs.org.

778 views • 47 slides

Meta-analysis in animal health and reproduction: methods and applications using Stata

Meta-analysis in animal health and reproduction: methods and applications using Stata. Ahmad Rabiee Ian Lean. PO Box 660 Camden 2570, NSW SBS cibus .com.au. Meta-analysis. Literature search study quality assessment Selection criteria Statistical analysis Heterogeneity

1.26k views • 42 slides

Metabolic Syndrome, Diabetes, and Cardiovascular Disease: Implications for Preventive Cardiology

Metabolic Syndrome, Diabetes, and Cardiovascular Disease: Implications for Preventive Cardiology. Nathan D. Wong, PhD, FACC, FAHA Professor and Director Heart Disease Prevention Program Division of Cardiology University of California, Irvine. Overview of Diabetes in the United States.

578 views • 36 slides

Main points to be covered

Main points to be covered. Measures of association compare measures of disease occurrence between levels of a predictor variable (eg, exposed/unexposed) Disease incidence and risk in a cohort study Absolute risk vs. relative risk Properties of the 2 X 2 table: Relative risk vs. odds ratio.

732 views • 31 slides

16: Odds Ratios [from case-control studies]

16: Odds Ratios [from case-control studies]. Case-control studies get around several limitations of cohort studies. Cohort Studies (Prior Chapter). Use incidences to assess risk Exposed cohort ? incidence 1 Non-exposed cohort ? incidence 0 Compare incidences via risk ratio (?).

902 views • 28 slides

487 views • 25 slides

405 views • 25 slides

Next steps after looking at equity data

Next steps after looking at equity data. Federal Grant Programs Conference November 2, 2018. 01. More about equity data. AGENDA. 02. Next steps after SLE data. 03. Bellingham Public Schools. 04. Revere Public Schools. 05. Small-group brainstorming. More about equity data.

335 views • 24 slides

Benefit-Risk Reevaluation of Marketed Drugs

Benefit-Risk Reevaluation of Marketed Drugs. Victor F. C. Raczkowski, M.D., M.S. Gastrointestinal Drugs Advisory Committee 27 June 2000. FDA Presentations: Themes. Benefit-Risk Evaluation of Lotronex Potential Benefits of Lotronex Potential Risks of Lotronex

410 views • 20 slides

Case-control study 1 : Design and odds ratio

Case-control study 1 : Design and odds ratio. Preben Aavitsland (partly based on Epiet 2004). Contents. Monday 1 Design: Case-control study as a smarter cohort study The odds ratio Tuesday 2 Choosing cases and controls Matching Power calculation Wednesday

622 views • 20 slides

A Stylized Introduction to Duration Models

A Stylized Introduction to Duration Models. Brad Jones Dept. of Political Science University of California, Davis. The Event. Getting a job Losing a job Business Failure Government Falls Politician Loses Regime Change Policy is Adopted Military Conflict Begins

326 views • 20 slides

Selecting a Study Design

Selecting a Study Design. Goals. Describe the cohort study design. Describe the case-control study design. Compare situations in which cohort and case-control study designs should be used. About Analytic Studies. We can use analytic studies to test hypotheses. We want to know:

483 views • 19 slides

Epidemiological study designs Causation

Epidemiological study designs Causation. Epidemiology. Descriptive - ecological Cross-sectional Cohort studies - Prospective - Retrospective Case-Control Experimental (intervention). Epidemiological-Clinical. Human subjects Clinical - focus on individual disease cases

697 views • 16 slides

CURRENT STATUS AND FUTURE PERSPECTIVES OF DRUG INFORMATION SYSTEMS

CURRENT STATUS AND FUTURE PERSPECTIVES OF DRUG INFORMATION SYSTEMS. T. Tervonen (1), V. Oskuee (1) , E.O. de Brock (1), P.A. de Graeff (2), H.L. Hillege (3) Faculty of Economics and Business, RUG.nl Department of Clinical Pharmacology & Internal Medicine, UMCG.nl

136 views • 1 slides